Dr. med. Armin Atzinger

Department of Nuclear Medicine

Unconventional Imaging Methods in Psoriatic Arthritis (2025) Minopoulou I, Fagni F, Atzinger A, Albach F, Schett G, Krönke G, Kleyer A, Simon D Journal article, Review article FDG-PET/CT as a useful tool for disease activity assessment in large vessel vasculitis in childhood (2025) Krickau T, Atzinger A, Jüngert JM, Rech J, Rompel O, Hörning A Journal article, Letter BCMA CAR T cells in a patient with relapsing idiopathic inflammatory myositis after initial and repeat therapy with CD19 CAR T cells (2025) Müller F, Wirsching A, Hagen M, Völkl S, Tur C, Raimondo MG, Taubmann J, et al. Journal article Evaluation of fibroblast activation protein-specific PET/CT in a patient with post-COVID pneumonitis (2024) Musameh K, O'Brien S, Mehboob R, Butler T, Cunningham Z, Buckley C, Atzinger A, et al. Journal article Fibroblast activation in sarcoidosis as assessed by 68Ga-FAPI (fibroblast activation protein inhibitor)-46 PET/CT (2024) O’Brien S, Musameh K, Obeid ME, Butler T, Armstrong M, Cunningham Z, Atzinger A, et al. Journal article Anatomical pattern of entheseal and synovial fibroblast activation in patients with psoriasis and its risk of developing psoriatic arthritis (2024) Corte G, Atzinger A, Temiz SA, Noversa de Sousa R, Mutlu MY, Schönau V, Raimondo MG, et al. Journal article Metabolic and molecular imaging in inflammatory arthritis (2024) Noversa de Sousa R, Tascilar K, Corte G, Atzinger A, Minopoulou I, Ohrndorf S, Waldner M, et al. Journal article, Review article CD200+ fibroblasts form a pro-resolving mesenchymal network in arthritis (2024) Rauber S, Mohammadian H, Schmidkonz C, Atzinger A, Soare A, Treutlein C, Kemble S, et al. Journal article Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodies (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kleyer A, Gary R, et al. Journal article, Letter Comment on: Rescue therapy of anti-synthetase syndrome with CD19-targeted CART cells after failure of several B cell-depleting antibodies: reply. (2024) Taubmann J, Knitza J, Müller F, Völkl S, Aigner M, Kretschmann S, Atzinger A, et al. Journal article